Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?

被引：0
作者：
Nosratola D Vaziri
机构：
[1] ND Vaziri is Professor of Medicine,Physiology and Biological Science and Director of the Division of Nephrology and Hypertension at the University of California
[2] Irvine,undefined
[3] CA,undefined
[4] USA.,undefined
来源：
Nature Clinical Practice Nephrology | 2008年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In this Review, Nosratola Vaziri endeavors to reconcile two apparently conflicting sets of evidence from patients with chronic kidney disease: the observational association between greater severity of anemia and increased risk of poor outcomes, and the increased risk of adverse outcomes in patients assigned to normal, rather than subnormal, hemoglobin targets in randomized clinical trials. The author focuses on data from basic and translational studies, which are often overlooked in the design and interpretation of clinical studies and in the formulation of clinical guidelines.
引用
收藏
页码：436 / 445
页数：9
相关论文
共 128 条
[1]  
Stenvinkel P(2001)The role of inflammation in the anaemia of end-stage renal disease Nephrol Dial Transplant 16 36-40
[2]  
Locatelli F(2006)Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients Nephrol Dial Transplant 21 991-998
[3]  
Attallah N(2006)Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia Am J Kidney Dis 47 644-654
[4]  
Lin CL(2003)Low dose intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in diabetic hemodialysis patients with iron overload Ren Fail 25 445-453
[5]  
Himmelfarb J(2002)The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia Kidney Int 62 1524-1538
[6]  
Himmelfarb J(2003)Oxidative stress in uremia Curr Opin Nephrol Hypertens 12 593-598
[7]  
Hakim RM(2006)Inflammation in end-stage renal disease: the hidden enemy Nephrology (Carlton) 11 36-41
[8]  
Stenvinkel P(2002)Mitochondrial DNA mutations and oxidative damage in skeletal muscle of patients with chronic uremia J Biomed Sci 9 549-560
[9]  
Lim PS(2004)Oxidative stress in uremia: nature, mechanisms and potential consequences Semin Nephrol 24 469-473
[10]  
Vaziri ND(2004)Roles of oxidative stress and antioxidant therapy in chronic renal disease and hypertension Curr Opin Nephrol Hypertens 13 93-99
12345678910